Alnylam Pharmaceuticals Inc. (ALNY)

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

1,300,000 $212,277 +21% 3.87%
2.
Farallon Capital

Thomas Steyer

1,023,873 $167,188 -14% 0.88%
3.
Casdin Capital

Eli Casdin

1,000,000 $163,290 7.32%
4.
Holocene Advisors

Brandon Haley

799,222 $130,505 +11% 0.68%
5. 463,663 $75,712 4.85%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$178.60 175 Director 1,000 2022-04-01 Filing
$177.58 825 Director 1,175 2022-04-01 Filing
$176.51 526 Director 2,000 2022-04-01 Filing
$174.33 90 Director 2,526 2022-04-01 Filing
$173.06 642 Director 2,616 2022-04-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 605,165 $98,817,395 0.04%
2. 66,700 $10,891,443 0.01%
3. 21,355 $3,487,058 0.02%
4. 16,045,316 $2,620,040 0.2%
5. 10,829,144 $1,768,291 0.04%
News See All